FAT jabs may lower the risk of the UK’s biggest killer, according to a study of almost 400,000 adults with type 2 diabetes. The research, published in JAMA Neurology, examined two types of ...
SGLT2 inhibitor use was not associated with an increased risk for postoperative diabetic ketoacidosis among patients with type 2 diabetes.
Type 2 diabetes mellitus (T2DM) is a major public health challenge in India, with an estimated 101 million individuals ...
Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based ...
The study found that some people taking SGLT2 inhibitors developed a dangerous infection called Fournier gangrene. This ...
Astrasentan becomes the first and only endothelin A receptor antagonist to focus on proteinuria reduction in primary ...
FDA grants accelerated approval to Novartis' Vanrafia for IgA nephropathy, with Phase 3 data in 2026 expected to support ...
In patients with heart failure, SGLT2 inhibitors after TAVI are associated with major risk reductions in a clinical trial ...
Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...
The following is a summary of “YouTube as a source of information for stroke rehabilitation: a cross-sectional analysis of ...
The following is a summary of “Optimizing SGLT2 inhibitor and GLP-1 RA prescribing in high-risk patients with diabetes: a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback